Navigation Links
Taking the needle's sting out of diabetes
Date:8/10/2009

T cells are the immune system's "soldiers" that fight off infection and disease. In her studies in the lab, when Mor blocked Ras using the FTS drug, she was able to increase the Foxp3 protein which gave a boost to the all-important T cells.

Slowing diabetes to a crawl

Mor then theorized that if the amount of regulatory T cells in the body was increased, the progression of diabetes would diminish. "My aim was to slow down diabetes, which brings a suitcase of side-effects like circulatory problems that lead to blindness and amputations," she says.

In her recent study, Mor treated pre-diabetic mice for six months. One group was given FTS, another was given no drug at all. The outcome was dramatic. Only 16% of the treated group developed diabetes, while 82% of the untreated group became diabetic. Also, insulin production from beta cells in the treated group of mice increased in comparison to insulin production in the non-treated group, she reports.

"Diabetes is my main concern," Mor concludes. "So many children and adults continue to suffer from the disorder. Since the FTS molecule is very easily absorbed into the blood, it could be the first diabetes treatment in pill form to moderate insulin production in juvenile diabetes, slowing down the progression of the disease. It could help a lot of people."


'/>"/>

Contact: George Hunka
ghunka@aftau.org
212-742-9070
American Friends of Tel Aviv University
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Mathematics taking guesswork out of plastic surgery tissue transfer
2. Looking to Shape Up for Summer? The Solution May Be the Steps Youre Already Taking
3. Swine Flu Vaccine Taking Longer Than Expected
4. Drug Limits Stomach Trouble in Patients Taking Low-Dose Aspirin
5. Looking to Shape up for Summer? The Solution May be the Steps Youre Already Taking
6. Taking Aim at Relapse of Leukemia in Kids
7. Value of Taking Aspirin to Cut Heart Risk Varies
8. Financial Distress Taking Toll on Employee Health
9. Taking a Bite Out of Rabies: Merial Provides Rabies Awareness and Prevention Training to Noahs Wish Pet Disaster Relief Organization
10. Chronic diarrhea unresponsive to conventional medication: Are you taking lansoprazole?
11. Taking folic acid for a year before pregnancy may reduce risk of preterm birth
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Taking the needle's sting out of diabetes
(Date:7/29/2015)... ... July 29, 2015 , ... Conventional theories used by ... goods and services may be able to unlock mysteries about the behavior of microbial ... , Boston University, and Columbia University. , The findings, published July 29 in the ...
(Date:7/29/2015)... Port Richey, FL (PRWEB) , ... July 29, ... ... the nation have become increasingly aware of the impact drinking and substance abuse ... and increased illness. Financial loss is tagged in the billions per year. [1] ...
(Date:7/29/2015)... ... ... " Core Organizer ” was featured on NewsWatch as part of its ... market for iOS, Android, and Windows. Joe Toohey, the host of AppWatch and technology ... anyone get organized. , Wouldn’t it be great if everyone could be a little ...
(Date:7/29/2015)... ... July 29, 2015 , ... More ... and service providers of children living with autism will converge upon Penn State ... demographic. , The National Autism Conference will be held Aug. 3-6 at ...
(Date:7/29/2015)... ... ... According to The Spirits Business on July 16th, a new study ... perpetuating alcohol use disorders. Humans have the same gene, which is called Rsu1. The ... and has given researchers inklings to explore Rsu1 in humans to abate alcohol addiction ...
Breaking Medicine News(10 mins):Health News:University Researchers Apply Economic Concepts to Explore the Mysteries of the Microbial World 2Health News:University Researchers Apply Economic Concepts to Explore the Mysteries of the Microbial World 3Health News:Workplace Trouble: Survey Reveals Sharp Escalation in Restaurant/Food Service Employee Drug Abuse 2Health News:Workplace Trouble: Survey Reveals Sharp Escalation in Restaurant/Food Service Employee Drug Abuse 3Health News:Get More Organized with the Core Organizer App 2Health News:Penn State Conference to Address Instruction, Success for Children with Autism 2Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 2Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 3
... link between secondhand smoke and an increased risk of Mycobacterium ... someone with TB, according to a study published in the ... could be a "cause of great concern considering the high ... den Boon of KNCV Tuberculosis Foundation in the Netherlands said. ...
... of dramatic proportions”, a study finding which says that hormone ... the risks of heart disease. , The study ... that hormone replacement therapy or HRT, taken by women in ... of heart attacks and other such conditions. , ...
... But there too strident voices are being raised in favor ... ensure availability of lower-cost copies of biotechnology drugs that now ... ,Generics are now allowed only for traditional, chemical ... complex biological drugs such as hormones or antibodies used in ...
... Engineers at the Johns Hopkins Urology Robotics Lab report ... that can safely power remote-controlled // robotic medical devices ... resonance imaging. The motor that drives the devices can ... steadier and more precise than a human hand. ...
... The US-based ImClone Systems and Bristol-Myers Squibb have announced ... combined with platinum-based //chemotherapy have increased survival chances among ... of the head and neck (SCCHN). ,Worldwide ... the head and neck, and approximately two-thirds of all ...
... good on his legs, even with the aid of a walking ... - no, decades - younger. ,Thurano believes he is ... found an active centenarian acrobat to disprove this, so it's probably ... Kassel, he did a few pull-ups to a wire to demonstrate. ...
Cached Medicine News:Health News:Study Finds Link Between Secondhand Smoke and TB Infection in Children 2Health News:Hormone Replacement Therapy- Not A Fallen Angel 2Health News:Law Emerging in US for Generic Versions of Biotech Medicine 2Health News:Law Emerging in US for Generic Versions of Biotech Medicine 3Health News:MRI Robotic Biopsies Simplified by PneuStep 2Health News:A New Erbitux Combo Shows Promise in treatment 2Health News:World's Oldest High-wire Artiste Hums Along at 98 2
(Date:7/29/2015)...   KaloBios Pharmaceuticals, Inc . (Nasdaq: KBIO ... therapies to benefit patients with diseases of unmet medical ... the U.S. Food and Drug Administration (FDA) has cleared ... an anti-GM-CSF monoclonal antibody (mAb), in patients with chronic ... active. The acceptance of this IND allows ...
(Date:7/29/2015)... , July 27, 2015 Research and ... of the "Global Neurostimulation Devices Market 2015" ... analysts forecast the global neurostimulation devices market to ... period 2014-2019. The report, Global Neurostimulation ... an in-depth market analysis with inputs from industry ...
(Date:7/29/2015)... a privately-held regenerative medicine company with the first stem cell-derived islet ... announced the opening of a second site in its Phase 1/2 ... and E fficacy of VC-01™ Combination P roduct in ... first in Canada , will be at the ... The lead Edmonton investigator ...
Breaking Medicine Technology:KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 2KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 3KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 4KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 5Global Neurostimulation Devices Market 2015-2019 2ViaCyte Announces Second Clinical Trial Site at University of Alberta 2ViaCyte Announces Second Clinical Trial Site at University of Alberta 3ViaCyte Announces Second Clinical Trial Site at University of Alberta 4